Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds - magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort.
Adrian WłodarczakPiotr RolaMateusz BaryckiŁukasz FurtanMagdalena ŁanochaSzymon WłodarczakMarek SzudrowiczJan Jakub KulczyckiJoanna Jaroszewska-PozorskaMichalina KędzierskaKatarzyna GiniewiczAdrian DoroszkoMaciej LesiakPublished in: Diabetes & vascular disease research (2023)
2-years outcome suggests good safety and efficacy of the magnesium BRS (Magmaris) in NSTE- ACS and concomitant DM. Nevertheless, there is a strong need for large multicenter, randomized, prospective studies for a full assessment of this novel device in diabetic patients with ACS.